These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 7289460)

  • 1. [Use of imidazoline derivatives in patients with arterial hypertension].
    Ol'binskaia LI; Enikeeva NB; Sinopal'nikov AI
    Klin Med (Mosk); 1980 Jul; 58(7):28-33. PubMed ID: 7289460
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the therapy of hypertension with an imidazoline derivative].
    Krause W; Krämer D; Grünitz B
    Med Klin; 1969 Jul; 64(28):1274-6. PubMed ID: 5799785
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical evaluation of imidazoline hydrochloride, alone or in combination with hydrochlorothiazide, in outpatient hypertensive patients].
    Miziara LJ; Zorzo DO; Silva EE
    Arq Bras Cardiol; 1973 Feb; 26(1):57-61. PubMed ID: 4731937
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical experimentation with a new imidazoline derivative (ST155) in the treatment of arterial hypertension].
    Ferreira EB; Eichemberg R; Berlitz MF
    Hospital (Rio J); 1969 Jun; 75(6):2139-51. PubMed ID: 5311472
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of an imidazoline derivative on arterial hypertension with or without associated toxemia].
    Delgado Urdapilleta J; Castro Carvajal F
    Ginecol Obstet Mex; 1969 Mar; 25(149):253-6. PubMed ID: 5780802
    [No Abstract]   [Full Text] [Related]  

  • 6. [1st results with a new antihypertensive agent; or imidazoline hydrochloride (ST 155)].
    Faerchtein I; Francisco Roque A; Kastansky I; Kac LB
    Hospital (Rio J); 1969 May; 75(5):1691-700. PubMed ID: 5306498
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hypotensive effect of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride].
    Palagi L; D'Elia M; Lanzara P; Criscione SM
    Clin Ter; 1970 Jun; 53(6):515-25. PubMed ID: 5527427
    [No Abstract]   [Full Text] [Related]  

  • 8. [Preliminary clinical experiences on the antihypertensive effect of 2-(2-6 diclorophenylamino)-imidazoline].
    Corsini G; Di Filippo A; Cioffi A
    Rass Int Clin Ter; 1971 Feb; 51(4):237-46. PubMed ID: 5576946
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical experience with a new hypotensive drug: 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST-155)].
    Langer-Costanzi M
    Clin Ter; 1970 Dec; 55(5):419-31. PubMed ID: 5516107
    [No Abstract]   [Full Text] [Related]  

  • 10. [The use of catapresan in the treatment of arterial hypertension].
    Teodorescu P; Cîmpeanu A
    Med Interna (Bucur); 1970 Dec; 22(12):1475-86. PubMed ID: 5502468
    [No Abstract]   [Full Text] [Related]  

  • 11. Safety and efficacy of moxonidine in mild to moderate hypertension.
    Jain S; Malhotra P; Kumari S; Varma S
    J Assoc Physicians India; 2001 Aug; 49():829-30. PubMed ID: 11837474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapy of elemental arterial hypertension by a new imidazole derivative].
    Valdés EF; Mendoza R; Gonçalves N
    Prensa Med Argent; 1967 Nov; 54(37):2068-71. PubMed ID: 5613692
    [No Abstract]   [Full Text] [Related]  

  • 13. [A drug for therapy of essential hypertension].
    Meoni S; Costa S; Rossi R
    Minerva Med; 1971 Apr; 62(30):1581-7. PubMed ID: 5577288
    [No Abstract]   [Full Text] [Related]  

  • 14. [Long-term antihypertensive therapy with moxonidine (cynt) in patients with insulin-independent diabetes mellitus].
    Lazebnik LB; Malichenko SB; Serebrov AN
    Ter Arkh; 1997; 69(6):59-64. PubMed ID: 9297279
    [No Abstract]   [Full Text] [Related]  

  • 15. [The use of melaxen in combined therapy of arterial hypertension in subjects occupied in assembly line production].
    Zamotaev IuN; Enikeev AKh; Kolomoets NM
    Klin Med (Mosk); 2009; 87(6):46-9. PubMed ID: 19670717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective imidazoline agonist moxonidine in obese hypertensive patients.
    Sanjuliani AF; de Abreu VG; Francischetti EA
    Int J Clin Pract; 2006 May; 60(5):621-9. PubMed ID: 16700870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The first clinical experience in Italy with angiotensin II receptor antagonists: results of a multicenter study on the efficacy and tolerance in arterial hypertension].
    Trimarco B
    Cardiologia; 1995 Dec; 40(12 Suppl 1):193-5. PubMed ID: 8998714
    [No Abstract]   [Full Text] [Related]  

  • 18. [Moxonidine vs. captopril in minor to intermediate hypertension. Double-blind study of effectiveness and tolerance].
    Lotti G; Gianrossi R
    Fortschr Med; 1993 Sep; 111(27):429-32. PubMed ID: 8225149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [On long term treatment of hypertension in ambulatory practice with an imidazoline derivative].
    Schwarz FK; Schwarz MT
    Landarzt; 1968 Feb; 44(4):191-4. PubMed ID: 4976526
    [No Abstract]   [Full Text] [Related]  

  • 20. Moxonidine in the treatment of overweight and obese patients with the metabolic syndrome: a postmarketing surveillance study.
    Sharma AM; Wagner T; Marsalek P
    J Hum Hypertens; 2004 Sep; 18(9):669-75. PubMed ID: 15269705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.